{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:20:46Z","timestamp":1790886046945,"version":"4.1.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001636"],"award-info":[{"award-number":["MOH-001636"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001356"],"award-info":[{"award-number":["MOH-001356"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000955"],"award-info":[{"award-number":["MOH-000955"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["AcRF Tier 1 Grant (RT1\/22)"],"award-info":[{"award-number":["AcRF Tier 1 Grant (RT1\/22)"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s41030-025-00339-6","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:10:35Z","timestamp":1767035435000},"page":"79-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fungal-Associated Endotypes as a Treatable Trait in Bronchiectasis"],"prefix":"10.1007","volume":"12","author":[{"given":"Kai Xian","family":"Thng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miche\u00e1l","family":"Mac Aog\u00e1in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0417-7607","authenticated-orcid":false,"given":"Sanjay H.","family":"Chotirmall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"339_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","volume":"4","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Chang AB, Chotirmall SH, et al. Bronchiectasis. Nat Rev Dis Primers. 2018;4:45. https:\/\/doi.org\/10.1038\/s41572-018-0042-3.","journal-title":"Nat Rev Dis Primers"},{"key":"339_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMra2202819","volume":"387","author":"AE O'Donnell","year":"2022","unstructured":"O\u2019Donnell AE. Bronchiectasis\u2014a clinical review. N Engl J Med. 2022;387:533\u201345. https:\/\/doi.org\/10.1056\/NEJMra2202819.","journal-title":"N Engl J Med"},{"key":"339_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/s0140-6736(18)31767-7","volume":"392","author":"PA Flume","year":"2018","unstructured":"Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392:880\u201390. https:\/\/doi.org\/10.1016\/s0140-6736(18)31767-7.","journal-title":"Lancet"},{"key":"339_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2024","author":"L Perea","year":"2024","unstructured":"Perea L, Faner R, Chalmers JD, et al. Pathophysiology and genomics of bronchiectasis. Eur Respir Rev. 2024. https:\/\/doi.org\/10.1183\/16000617.0055-2024.","journal-title":"Eur Respir Rev"},{"key":"339_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/s2213-2600(18)30053-5","volume":"6","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018;6:715\u201326. https:\/\/doi.org\/10.1016\/s2213-2600(18)30053-5.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"339_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0638-0","volume":"18","author":"R Chandrasekaran","year":"2018","unstructured":"Chandrasekaran R, Mac Aog\u00e1in M, Chalmers JD, et al. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med. 2018;18(1):83. https:\/\/doi.org\/10.1186\/s12890-018-0638-0.","journal-title":"BMC Pulm Med"},{"key":"339_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s2213-2600(23)00093-0","volume":"11","author":"JD Chalmers","year":"2023","unstructured":"Chalmers JD, Polverino E, Crichton ML, et al. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023;11:637\u201349. https:\/\/doi.org\/10.1016\/s2213-2600(23)00093-0.","journal-title":"Lancet Respir Med"},{"key":"339_CR8","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0119-2021","volume":"17","author":"T Pembridge","year":"2021","unstructured":"Pembridge T, Chalmers JD. Precision medicine in\u00a0bronchiectasis. Breathe. 2021;17:210119. https:\/\/doi.org\/10.1183\/20734735.0119-2021.","journal-title":"Breathe"},{"key":"339_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202403-0473PP","volume":"210","author":"SH Chotirmall","year":"2024","unstructured":"Chotirmall SH, Chalmers JD. The precision medicine era of bronchiectasis. Am J Respir Crit Care Med. 2024;210:24\u201334. https:\/\/doi.org\/10.1164\/rccm.202403-0473PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"339_CR10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01269-2018","author":"R Boaventura","year":"2018","unstructured":"Boaventura R, Sibila O, Agusti A, et al. Treatable traits in bronchiectasis. Eur Respir J. 2018. https:\/\/doi.org\/10.1183\/13993003.01269-2018.","journal-title":"Eur Respir J"},{"key":"339_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pulmoe.2023.03.004","volume":"29","author":"M Martins","year":"2023","unstructured":"Martins M, Keir HR, Chalmers JD. Endotypes in bronchiectasis: moving towards precision medicine. A narrative review. Pulmonology. 2023;29:505\u201317. https:\/\/doi.org\/10.1016\/j.pulmoe.2023.03.004.","journal-title":"Pulmonology"},{"key":"339_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0038-2024","author":"M Mac Aog\u00e1in","year":"2024","unstructured":"Mac Aog\u00e1in M, Dicker AJ, Mertsch P, et al. Infection and the microbiome in bronchiectasis. Eur Respir Rev. 2024. https:\/\/doi.org\/10.1183\/16000617.0038-2024.","journal-title":"Eur Respir Rev"},{"key":"339_CR13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01551-2024","author":"JD Chalmers","year":"2025","unstructured":"Chalmers JD, Shteinberg M, Mall MA, et al. Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase\u00a0II randomised, double-blind, placebo-controlled, dose-finding study. Eur Respir J. 2025. https:\/\/doi.org\/10.1183\/13993003.01551-2024.","journal-title":"Eur Respir J"},{"key":"339_CR14","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00633-2022","author":"JD Chalmers","year":"2023","unstructured":"Chalmers JD, Gupta A, Chotirmall SH, et al. A phase\u00a02 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: airleaf. ERJ Open Res. 2023. https:\/\/doi.org\/10.1183\/23120541.00633-2022.","journal-title":"ERJ Open Res"},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","volume":"383","author":"JD Chalmers","year":"2020","unstructured":"Chalmers JD, Haworth CS, Metersky ML, et al. Phase\u00a02 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N Engl J Med. 2020;383:2127\u201337. https:\/\/doi.org\/10.1056\/NEJMoa2021713.","journal-title":"N Engl J Med"},{"key":"339_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s11046-021-00539-z","volume":"186","author":"PY Tiew","year":"2021","unstructured":"Tiew PY, Mac Aog\u00e1in M, Ter SK, et al. Respiratory mycoses in COPD and bronchiectasis. Mycopathologia. 2021;186:623\u201338. https:\/\/doi.org\/10.1007\/s11046-021-00539-z.","journal-title":"Mycopathologia"},{"key":"339_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jof8050480","author":"PY Tiew","year":"2022","unstructured":"Tiew PY, Thng KX, Chotirmall SH. Clinical Aspergillus signatures in COPD and bronchiectasis. J Fungi. 2022. https:\/\/doi.org\/10.3390\/jof8050480.","journal-title":"J Fungi"},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1055\/s-0041-1730947","volume":"42","author":"TK Jaggi","year":"2021","unstructured":"Jaggi TK, Ter SK, Mac Aog\u00e1in M, et al. Aspergillus-associated endophenotypes in bronchiectasis. Semin Respir Crit Care Med. 2021;42:556\u201366. https:\/\/doi.org\/10.1055\/s-0041-1730947.","journal-title":"Semin Respir Crit Care Med"},{"key":"339_CR19","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1093\/mmy\/myy076","volume":"57","author":"S Gago","year":"2019","unstructured":"Gago S, Denning DW, Bowyer P. Pathophysiological aspects of Aspergillus colonization in disease. Med Mycol. 2019;57:S219\u201327. https:\/\/doi.org\/10.1093\/mmy\/myy076.","journal-title":"Med Mycol"},{"key":"339_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010142","author":"L M\u00e1iz","year":"2018","unstructured":"M\u00e1iz L, Nieto R, Cant\u00f3n R, et al. Fungi in bronchiectasis: a concise review. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19010142.","journal-title":"Int J Mol Sci"},{"key":"339_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1183\/13993003.01888-2015","volume":"48","author":"S Aliberti","year":"2016","unstructured":"Aliberti S, Masefield S, Polverino E, et al. Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration. Eur Respir J. 2016;48:632\u201347. https:\/\/doi.org\/10.1183\/13993003.01888-2015.","journal-title":"Eur Respir J"},{"issue":"207\u2013231","key":"339_CR22","doi-asserted-by":"publisher","first-page":"20200101","DOI":"10.1007\/s11046-019-00413-z","volume":"185","author":"PY Tiew","year":"2020","unstructured":"Tiew PY, Mac Aogain M, Ali N, et al. The mycobiome in health and disease: emerging concepts, methodologies and challenges. Mycopathologia. 2020;185(207\u2013231):20200101. https:\/\/doi.org\/10.1007\/s11046-019-00413-z.","journal-title":"Mycopathologia"},{"key":"339_CR23","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1164\/rccm.201807-1355OC","volume":"199","author":"M Mac Aog\u00e1in","year":"2019","unstructured":"Mac Aog\u00e1in M, Tiew PY, Lim AYH, et al. Distinct \u201cimmunoallertypes\u201d of disease and high frequencies of sensitization in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2019;199:842\u201353. https:\/\/doi.org\/10.1164\/rccm.201807-1355OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"339_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00766-2018","author":"M Mac Aog\u00e1in","year":"2018","unstructured":"Mac Aog\u00e1in M, Chandrasekaran R, Lim AYH, et al. Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study. Eur Respir J. 2018. https:\/\/doi.org\/10.1183\/13993003.00766-2018.","journal-title":"Eur Respir J"},{"issue":"975\u2013992","key":"339_CR25","doi-asserted-by":"publisher","first-page":"20241024","DOI":"10.1016\/j.chest.2024.06.3843","volume":"167","author":"J Pollock","year":"2025","unstructured":"Pollock J, Goeminne PC, Aliberti S, et al. Aspergillus serologic findings and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry. Chest. 2025;167(975\u2013992):20241024. https:\/\/doi.org\/10.1016\/j.chest.2024.06.3843.","journal-title":"Chest"},{"key":"339_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00061-2024","author":"R Agarwal","year":"2024","unstructured":"Agarwal R, Sehgal IS, Muthu V, et al. Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses. Eur Respir J. 2024. https:\/\/doi.org\/10.1183\/13993003.00061-2024.","journal-title":"Eur Respir J"},{"issue":"2","key":"339_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MCP.0000000000001131","volume":"31","author":"JK Narayana","year":"2025","unstructured":"Narayana JK, Mac Aogain M, Hansbro PM, et al. The bronchiectasis microbiome: current understanding and treatment implications. Curr Opin Pulm Med. 2025;31(2):135\u201344. https:\/\/doi.org\/10.1097\/MCP.0000000000001131.","journal-title":"Curr Opin Pulm Med"},{"key":"339_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1164\/rccm.202205-0893OC","volume":"207","author":"JK Narayana","year":"2023","unstructured":"Narayana JK, Aliberti S, Mac Aog\u00e1in M, et al. Microbial dysregulation of the gut-lung axis in bronchiectasis. Am J Respir Crit Care Med. 2023;207:908\u201320. https:\/\/doi.org\/10.1164\/rccm.202205-0893OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"339_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41591-021-01289-7","volume":"27","author":"M Mac Aog\u00e1in","year":"2021","unstructured":"Mac Aog\u00e1in M, Narayana JK, Tiew PY, et al. Integrative microbiomics in bronchiectasis exacerbations. Nat Med. 2021;27(4):688\u201399. https:\/\/doi.org\/10.1038\/s41591-021-01289-7.","journal-title":"Nat Med"},{"issue":"5","key":"339_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000381289","volume":"89","author":"L M\u00e1iz","year":"2015","unstructured":"M\u00e1iz L, Vendrell M, Olveira C, et al. Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis. Respiration. 2015;89(5):396\u2013403. https:\/\/doi.org\/10.1159\/000381289.","journal-title":"Respiration"},{"key":"339_CR31","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.rmed.2006.03.003","volume":"100","author":"T Mukaino","year":"2006","unstructured":"Mukaino T, Koga T, Oshita Y, et al. Exophiala dermatitidis infection in non-cystic fibrosis bronchiectasis. Respir Med. 2006;100:2069\u201371. https:\/\/doi.org\/10.1016\/j.rmed.2006.03.003.","journal-title":"Respir Med"},{"issue":"11","key":"339_CR32","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s10096-011-1229-7","volume":"30","author":"KL Mortensen","year":"2011","unstructured":"Mortensen KL, Johansen HK, Fuursted K, et al. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis. 2011;30(11):1355\u201363. https:\/\/doi.org\/10.1007\/s10096-011-1229-7.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"581\u2013587","key":"339_CR33","doi-asserted-by":"publisher","first-page":"20110105","DOI":"10.3109\/13693786.2010.548084","volume":"49","author":"T Tashiro","year":"2011","unstructured":"Tashiro T, Izumikawa K, Tashiro M, et al. Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Med Mycol. 2011;49(581\u2013587):20110105. https:\/\/doi.org\/10.3109\/13693786.2010.548084.","journal-title":"Med Mycol"},{"key":"339_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1439-0507.2002.00738.x","volume":"45","author":"A Chakrabarti","year":"2002","unstructured":"Chakrabarti A, Sethi S, Raman DS, et al. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses. 2002;45:295\u20139. https:\/\/doi.org\/10.1046\/j.1439-0507.2002.00738.x.","journal-title":"Mycoses"},{"issue":"982\u2013992","key":"339_CR35","doi-asserted-by":"publisher","first-page":"20161123","DOI":"10.1016\/j.chest.2016.10.055","volume":"151","author":"TR Aksamit","year":"2017","unstructured":"Aksamit TR, O\u2019Donnell AE, Barker A, et al. Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry. Chest. 2017;151(982\u2013992):20161123. https:\/\/doi.org\/10.1016\/j.chest.2016.10.055.","journal-title":"Chest"},{"issue":"6","key":"339_CR36","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/resp.12574","volume":"20","author":"Q Qi","year":"2015","unstructured":"Qi Q, Wang W, Li T, et al. Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: a prospective study. Respirology. 2015;20(6):917\u201324. https:\/\/doi.org\/10.1111\/resp.12574.","journal-title":"Respirology"},{"issue":"5","key":"339_CR37","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/imj.70020","volume":"55","author":"C Gibbs","year":"2025","unstructured":"Gibbs C, Howarth T, Venkatesan S, et al. Sputum microbiology data and related clinical outcomes among adult Aboriginal Australians with bronchiectasis. Intern Med J. 2025;55(5):784\u201394. https:\/\/doi.org\/10.1111\/imj.70020.","journal-title":"Intern Med J"},{"key":"339_CR38","doi-asserted-by":"publisher","first-page":"23299","DOI":"10.1073\/pnas.1908493116","volume":"116","author":"ES Gusareva","year":"2019","unstructured":"Gusareva ES, Acerbi E, Lau KJX, et al. Microbial communities in the tropical air ecosystem follow a precise diel cycle. Proc Natl Acad Sci USA. 2019;116:23299\u2013308. https:\/\/doi.org\/10.1073\/pnas.1908493116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"339_CR39","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2666-5247(24)00039-9","volume":"5","author":"D Seidel","year":"2024","unstructured":"Seidel D, Wurster S, Jenks JD, et al. Impact of climate change and natural disasters on fungal infections. Lancet Microbe. 2024;5:e594\u2013605. https:\/\/doi.org\/10.1016\/S2666-5247(24)00039-9.","journal-title":"Lancet Microbe"},{"issue":"4","key":"339_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009503","volume":"17","author":"NE Nnadi","year":"2021","unstructured":"Nnadi NE, Carter DA. Climate change and the emergence of fungal pathogens. PLoS Pathog. 2021;17(4):e1009503. https:\/\/doi.org\/10.1371\/journal.ppat.1009503.","journal-title":"PLoS Pathog"},{"key":"339_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/21505594.2015.1029219","volume":"6","author":"K Kaerger","year":"2015","unstructured":"Kaerger K, Schwartze VU, Dolatabadi S, et al. Adaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibility. Virulence. 2015;6:395\u2013403. https:\/\/doi.org\/10.1080\/21505594.2015.1029219.","journal-title":"Virulence"},{"key":"339_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12915-015-0127-3","volume":"13","author":"V Robert","year":"2015","unstructured":"Robert V, Cardinali G, Casadevall A. Distribution and impact of yeast thermal tolerance permissive for mammalian infection. BMC Biol. 2015;13:18. https:\/\/doi.org\/10.1186\/s12915-015-0127-3.","journal-title":"BMC Biol"},{"key":"339_CR43","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.cmi.2023.03.016","volume":"29","author":"V Garcia-Bustos","year":"2023","unstructured":"Garcia-Bustos V, Caba\u00f1ero-Navalon MD, Ruiz-Gait\u00e1n A, et al. Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a one health approach. Clin Microbiol Infect. 2023;29:858\u201362. https:\/\/doi.org\/10.1016\/j.cmi.2023.03.016.","journal-title":"Clin Microbiol Infect"},{"key":"339_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00360-21","author":"A Casadevall","year":"2021","unstructured":"Casadevall A, Kontoyiannis DP, Robert V. Environmental Candida auris and the global warming emergence hypothesis. MBio. 2021. https:\/\/doi.org\/10.1128\/mBio.00360-21.","journal-title":"MBio"},{"issue":"1","key":"339_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42679-4","volume":"14","author":"V Del Olmo","year":"2023","unstructured":"Del Olmo V, Mix\u00e3o V, Fotedar R, et al. Origin of fungal hybrids with pathogenic potential from warm seawater environments. Nat Commun. 2023;14(1):6919. https:\/\/doi.org\/10.1038\/s41467-023-42679-4.","journal-title":"Nat Commun"},{"issue":"1","key":"339_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58378-9","volume":"10","author":"M Maymon","year":"2020","unstructured":"Maymon M, Sela N, Shpatz U, et al. The origin and current situation of Fusarium oxysporum f. sp. cubense tropical race 4 in Israel and the Middle East. Sci Rep. 2020;10(1):1590. https:\/\/doi.org\/10.1038\/s41598-020-58378-9.","journal-title":"Sci Rep"},{"key":"339_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/life13071440","author":"A Cighir","year":"2023","unstructured":"Cighir A, Mare AD, Vultur F, et al. Fusarium spp. in human disease: exploring the boundaries between commensalism and pathogenesis. Life (Basel). 2023. https:\/\/doi.org\/10.3390\/life13071440.","journal-title":"Life (Basel)"},{"key":"339_CR48","doi-asserted-by":"publisher","first-page":"17474","DOI":"10.1073\/pnas.1003577107","volume":"107","author":"M Roper","year":"2010","unstructured":"Roper M, Seminara A, Bandi MM, et al. Dispersal of fungal spores on a cooperatively generated wind. Proc Natl Acad Sci USA. 2010;107:17474\u20139. https:\/\/doi.org\/10.1073\/pnas.1003577107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"339_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2221996120","volume":"120","author":"RJB Cordero","year":"2023","unstructured":"Cordero RJB, Mattoon ER, Ramos Z, et al. The hypothermic nature of fungi. Proc Natl Acad Sci USA. 2023;120:e2221996120. https:\/\/doi.org\/10.1073\/pnas.2221996120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"339_CR50","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1086\/652761","volume":"50","author":"AA Panackal","year":"2010","unstructured":"Panackal AA, Li H, Kontoyiannis DP, et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2010;50:1588\u201397. https:\/\/doi.org\/10.1086\/652761.","journal-title":"Clin Infect Dis"},{"key":"339_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbr.2022.10.005","volume":"44","author":"FJJ Segers","year":"2023","unstructured":"Segers FJJ, Dijksterhuis J, Giesbers M, et al. Natural folding of airborne fungal spores: a mechanism for dispersal and long-term survival? Fungal Biol Rev. 2023;44:100292. https:\/\/doi.org\/10.1016\/j.fbr.2022.10.005.","journal-title":"Fungal Biol Rev"},{"key":"339_CR52","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3201\/eid2003.131230","volume":"20","author":"K Benedict","year":"2014","unstructured":"Benedict K, Park BJ. Invasive fungal infections after natural disasters. Emerg Infect Dis. 2014;20:349\u201355. https:\/\/doi.org\/10.3201\/eid2003.131230.","journal-title":"Emerg Infect Dis"},{"key":"339_CR53","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41564-022-01203-y","volume":"7","author":"AR Nelson","year":"2022","unstructured":"Nelson AR, Narrowe AB, Rhoades CC, et al. Wildfire-dependent changes in soil microbiome diversity and function. Nat Microbiol. 2022;7:1419\u201330. https:\/\/doi.org\/10.1038\/s41564-022-01203-y.","journal-title":"Nat Microbiol"},{"key":"339_CR54","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1016\/s2542-5196(23)00046-3","volume":"7","author":"JS Mulliken","year":"2023","unstructured":"Mulliken JS, Hampshire KN, Rappold AG, et al. Risk of systemic fungal infections after exposure to wildfires: a population-based, retrospective study in California. Lancet Planet Health. 2023;7:e381\u20136. https:\/\/doi.org\/10.1016\/s2542-5196(23)00046-3.","journal-title":"Lancet Planet Health"},{"key":"339_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/ecs2.2507","volume":"9","author":"LN Kobziar","year":"2018","unstructured":"Kobziar LN, Pingree MRA, Larson H, et al. Pyroaerobiology: the aerosolization and transport of viable microbial life by wildland fire. Ecosphere. 2018;9:e02507. https:\/\/doi.org\/10.1002\/ecs2.2507.","journal-title":"Ecosphere"},{"key":"339_CR56","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.4187\/respcare.01701","volume":"57","author":"Y Kawakami","year":"2012","unstructured":"Kawakami Y, Tagami T, Kusakabe T, et al. Disseminated aspergillosis associated with tsunami lung. Respir Care. 2012;57:1674\u20138. https:\/\/doi.org\/10.4187\/respcare.01701.","journal-title":"Respir Care"},{"key":"339_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2741\/s477","volume":"9","author":"ACA Yii","year":"2017","unstructured":"Yii ACA, Koh MS, Lapperre TS, et al. The emergence of Aspergillus species in chronic respiratory disease. FBS. 2017;9:127\u201338. https:\/\/doi.org\/10.2741\/s477.","journal-title":"FBS"},{"issue":"2","key":"339_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.chest.2020.02.048","volume":"158","author":"TY Poh","year":"2020","unstructured":"Poh TY, Tiew PY, Lim AYH, et al. Increased chitotriosidase is associated with Aspergillus and frequent exacerbations in South-East Asian patients with bronchiectasis. Chest. 2020;158(2):512\u201322. https:\/\/doi.org\/10.1016\/j.chest.2020.02.048.","journal-title":"Chest"},{"issue":"1","key":"339_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000713","volume":"6","author":"MA Ghannoum","year":"2010","unstructured":"Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6(1):e1000713. https:\/\/doi.org\/10.1371\/journal.ppat.1000713.","journal-title":"PLoS Pathog"},{"issue":"2","key":"339_CR60","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.chest.2020.09.072","volume":"159","author":"N Ali","year":"2021","unstructured":"Ali N, Ivan FX, Mac Aog\u00e1in M, et al. The healthy airway mycobiome in individuals of Asian descent. Chest. 2021;159(2):544\u20138. https:\/\/doi.org\/10.1016\/j.chest.2020.09.072.","journal-title":"Chest"},{"key":"339_CR61","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/imj.70118","volume":"55","author":"T Howarth","year":"2025","unstructured":"Howarth T, Sorger L, Saad HB, et al. Indigenous bronchiectasis assessment scale\u2014the \u201cIBAS\u201d: a proposed new tool to assess bronchiectasis severity in adult Indigenous Australians. Intern Med J. 2025;55:1701\u201311. https:\/\/doi.org\/10.1111\/imj.70118.","journal-title":"Intern Med J"},{"issue":"1186\u20131195","key":"339_CR62","doi-asserted-by":"publisher","first-page":"20100514","DOI":"10.1378\/chest.09-2996","volume":"138","author":"SH Chotirmall","year":"2010","unstructured":"Chotirmall SH, O\u2019Donoghue E, Bennett K, et al. Sputum Candida albicans presages FEV1 decline and hospital-treated exacerbations in cystic fibrosis. Chest. 2010;138(1186\u20131195):20100514. https:\/\/doi.org\/10.1378\/chest.09-2996.","journal-title":"Chest"},{"key":"339_CR63","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1128\/iai.72.9.4996-5003.2004","volume":"72","author":"MC Noverr","year":"2004","unstructured":"Noverr MC, Noggle RM, Toews GB, et al. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun. 2004;72:4996\u20135003. https:\/\/doi.org\/10.1128\/iai.72.9.4996-5003.2004.","journal-title":"Infect Immun"},{"key":"339_CR64","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2019.01.041","volume":"176","author":"P Bacher","year":"2019","unstructured":"Bacher P, Hohnstein T, Beerbaum E, et al. Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans. Cell. 2019;176:1340-1355.e1315. https:\/\/doi.org\/10.1016\/j.cell.2019.01.041.","journal-title":"Cell"},{"issue":"1","key":"339_CR65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11046-017-0143-7","volume":"183","author":"SH Chotirmall","year":"2018","unstructured":"Chotirmall SH, Martin-Gomez MT. Aspergillus species in bronchiectasis: challenges in the cystic fibrosis and non-cystic fibrosis airways. Mycopathologia. 2018;183(1):45\u201359. https:\/\/doi.org\/10.1007\/s11046-017-0143-7.","journal-title":"Mycopathologia"},{"key":"339_CR66","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0058-2024","author":"E Van Braeckel","year":"2024","unstructured":"Van Braeckel E, Bosteels C. Growing from common ground: nontuberculous mycobacteria and bronchiectasis. Eur Respir Rev. 2024. https:\/\/doi.org\/10.1183\/16000617.0058-2024.","journal-title":"Eur Respir Rev"},{"key":"339_CR67","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3109\/13693786.2013.806826","volume":"51","author":"BW Jhun","year":"2013","unstructured":"Jhun BW, Jeon K, Eom JS, et al. Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis. Med Mycol. 2013;51:811\u20137. https:\/\/doi.org\/10.3109\/13693786.2013.806826.","journal-title":"Med Mycol"},{"issue":"2","key":"339_CR68","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1183\/09031936.06.00139005","volume":"28","author":"H Kunst","year":"2006","unstructured":"Kunst H, Wickremasinghe M, Wells A, et al. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J. 2006;28(2):352\u20137. https:\/\/doi.org\/10.1183\/09031936.06.00139005.","journal-title":"Eur Respir J"},{"key":"339_CR69","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/resp.12287","volume":"19","author":"Z Zoumot","year":"2014","unstructured":"Zoumot Z, Boutou AK, Gill SS, et al. Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis. Respirology. 2014;19:714\u201322. https:\/\/doi.org\/10.1111\/resp.12287.","journal-title":"Respirology"},{"key":"339_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195619","author":"M Fayos","year":"2022","unstructured":"Fayos M, Silva JT, L\u00f3pez-Medrano F, et al. Non-tuberculous mycobacteria and Aspergillus lung co-infection: systematic review. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11195619.","journal-title":"J Clin Med"},{"key":"339_CR71","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00803-2024","author":"TK Jaggi","year":"2024","unstructured":"Jaggi TK, Agarwal R, Tiew PY, et al. Fungal lung disease. Eur Respir J. 2024. https:\/\/doi.org\/10.1183\/13993003.00803-2024.","journal-title":"Eur Respir J"},{"key":"339_CR72","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/13693780500488939","volume":"44","author":"J Guinea","year":"2006","unstructured":"Guinea J, Pel\u00e1ez T, Alcal\u00e1 L, et al. Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area. Med Mycol. 2006;44:349\u201356. https:\/\/doi.org\/10.1080\/13693780500488939.","journal-title":"Med Mycol"},{"issue":"Suppl 1","key":"339_CR73","first-page":"137","volume":"36","author":"T Beffa","year":"1998","unstructured":"Beffa T, Staib F, Lott Fischer J, et al. Mycological control and surveillance of biological waste and compost. Med Mycol. 1998;36(Suppl 1):137\u201345.","journal-title":"Med Mycol"},{"key":"339_CR74","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/723129","volume":"2013","author":"SH Chotirmall","year":"2013","unstructured":"Chotirmall SH, Al-Alawi M, Mirkovic B, et al. Aspergillus-associated airway disease, inflammation, and the innate immune response. BioMed Res Int. 2013;2013:723129. https:\/\/doi.org\/10.1155\/2013\/723129.","journal-title":"BioMed Res Int"},{"key":"339_CR75","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","volume":"23","author":"MS Lionakis","year":"2023","unstructured":"Lionakis MS, Drummond RA, Hohl TM. Immune responses to human fungal pathogens and\u00a0therapeutic prospects. Nat Rev Immunol. 2023;23:433\u201352. https:\/\/doi.org\/10.1038\/s41577-022-00826-w.","journal-title":"Nat Rev Immunol"},{"key":"339_CR76","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/mmy\/myw109","volume":"55","author":"A De Soyza","year":"2017","unstructured":"De Soyza A, Aliberti S. Bronchiectasis and Aspergillus: how are they linked? Med Mycol. 2017;55:69\u201381. https:\/\/doi.org\/10.1093\/mmy\/myw109.","journal-title":"Med Mycol"},{"key":"339_CR77","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2222.1985.tb02311.x","volume":"15","author":"J Bahous","year":"1985","unstructured":"Bahous J, Malo JL, Paquin R, et al. Allergic bronchopulmonary aspergillosis and sensitization to Aspergillus fumigatus in chronic bronchiectasis in adults. Clin Allergy. 1985;15:571\u20139. https:\/\/doi.org\/10.1111\/j.1365-2222.1985.tb02311.x.","journal-title":"Clin Allergy"},{"key":"339_CR78","volume-title":"Future directions: the next 10\u00a0years in research","author":"SH Chotirmall","year":"2018","unstructured":"Chotirmall SH. Future directions: the next 10\u00a0years in research. Sheffield: European Respiratory Society; 2018."},{"key":"339_CR79","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2144\/btn-2020-0057","volume":"69","author":"H Zhu","year":"2020","unstructured":"Zhu H, Haoqing Z, Ying X, et al. PCR past, present and future. Biotechniques. 2020;69:317\u201325. https:\/\/doi.org\/10.2144\/btn-2020-0057.","journal-title":"Biotechniques"},{"issue":"4","key":"339_CR80","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019299","volume":"4","author":"TR Kozel","year":"2014","unstructured":"Kozel TR, Wickes B. Fungal diagnostics. Cold Spring Harb Perspect Med. 2014;4(4):a019299. https:\/\/doi.org\/10.1101\/cshperspect.a019299.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"236\u2013248","key":"339_CR81","doi-asserted-by":"publisher","first-page":"20180329","DOI":"10.1016\/j.mycmed.2018.03.001","volume":"28","author":"S Otasevic","year":"2018","unstructured":"Otasevic S, Momcilovic S, Stojanovic NM, et al. Non-culture based assays for the detection of fungal pathogens. J Mycol Med. 2018;28(236\u2013248):20180329. https:\/\/doi.org\/10.1016\/j.mycmed.2018.03.001.","journal-title":"J Mycol Med"},{"key":"339_CR82","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1164\/rccm.201906-1185ST","volume":"200","author":"CA Hage","year":"2019","unstructured":"Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019;200:535\u201350. https:\/\/doi.org\/10.1164\/rccm.201906-1185ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"339_CR83","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.15.3.465-484.2002","volume":"15","author":"SF Yeo","year":"2002","unstructured":"Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev. 2002;15:465\u201384. https:\/\/doi.org\/10.1128\/CMR.15.3.465-484.2002.","journal-title":"Clin Microbiol Rev"},{"key":"339_CR84","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12281-018-0321-1","volume":"12","author":"M Richardson","year":"2018","unstructured":"Richardson M, Page I. Role of serological tests in the diagnosis of mold infections. Curr Fungal Infect Rep. 2018;12:127\u201336. https:\/\/doi.org\/10.1007\/s12281-018-0321-1.","journal-title":"Curr Fungal Infect Rep"},{"issue":"Suppl 1","key":"339_CR85","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1\u201338. https:\/\/doi.org\/10.1016\/j.cmi.2018.01.002.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"339_CR86","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1128\/JCM.00345-17","volume":"55","author":"W Zhou","year":"2017","unstructured":"Zhou W, Li H, Zhang Y, et al. Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis. J Clin Microbiol. 2017;55(7):2153\u201361. https:\/\/doi.org\/10.1128\/JCM.00345-17.","journal-title":"J Clin Microbiol"},{"key":"339_CR87","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3109\/13693786.2013.777162","volume":"51","author":"XB Zhang","year":"2013","unstructured":"Zhang XB, Chen GP, Lin QC, et al. Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease. Med Mycol. 2013;51:688\u201395. https:\/\/doi.org\/10.3109\/13693786.2013.777162.","journal-title":"Med Mycol"},{"key":"339_CR88","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med. 2008;177:27\u201334. https:\/\/doi.org\/10.1164\/rccm.200704-606OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"339_CR89","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/femsre\/fuz015","volume":"43","author":"O Consortium","year":"2019","unstructured":"Consortium O, Gabaldon T. Recent trends in molecular diagnostics of yeast infections: from PCR to NGS. FEMS Microbiol Rev. 2019;43:517\u201347. https:\/\/doi.org\/10.1093\/femsre\/fuz015.","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"339_CR90","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1574-6976.2011.00298.x","volume":"36","author":"A Croxatto","year":"2012","unstructured":"Croxatto A, Prod\u2019hom G, Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 2012;36(2):380\u2013407. https:\/\/doi.org\/10.1111\/j.1574-6976.2011.00298.x.","journal-title":"FEMS Microbiol Rev"},{"issue":"5","key":"339_CR91","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41564-022-01091-2","volume":"7","author":"J Rhodes","year":"2022","unstructured":"Rhodes J, Abdolrasouli A, Dunne K, et al. Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nat Microbiol. 2022;7(5):663\u201374. https:\/\/doi.org\/10.1038\/s41564-022-01091-2.","journal-title":"Nat Microbiol"},{"key":"339_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/jof2030021","author":"O Rivero-Menendez","year":"2016","unstructured":"Rivero-Menendez O, Alastruey-Izquierdo A, Mellado E, et al. Triazole resistance in Aspergillus spp.: a worldwide problem? J Fungi. 2016. https:\/\/doi.org\/10.3390\/jof2030021.","journal-title":"J Fungi"},{"key":"339_CR93","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/jcm.01283-12","volume":"50","author":"SR Lockhart","year":"2012","unstructured":"Lockhart SR, Iqbal N, Cleveland AA, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol. 2012;50:3435\u201342. https:\/\/doi.org\/10.1128\/jcm.01283-12.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"339_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2015.04.002","volume":"30","author":"X Liao","year":"2015","unstructured":"Liao X, Qiu H, Li R, et al. Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: an analysis from the China Survey of Candidiasis study. J Crit Care. 2015;30(4):862.e861-865. https:\/\/doi.org\/10.1016\/j.jcrc.2015.04.002.","journal-title":"J Crit Care"},{"key":"339_CR95","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2217\/fmb-2016-0099","volume":"11","author":"H Wang","year":"2016","unstructured":"Wang H, Xu YC, Hsueh PR. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future Microbiol. 2016;11:1461\u201377. https:\/\/doi.org\/10.2217\/fmb-2016-0099.","journal-title":"Future Microbiol"},{"key":"339_CR96","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/cid\/civ885","volume":"62","author":"PE Verweij","year":"2016","unstructured":"Verweij PE, Chowdhary A, Melchers WJ, et al. Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis. 2016;62:362\u20138. https:\/\/doi.org\/10.1093\/cid\/civ885.","journal-title":"Clin Infect Dis"},{"issue":"32\u201340","key":"339_CR97","doi-asserted-by":"publisher","first-page":"20240109","DOI":"10.1055\/s-0043-1776997","volume":"45","author":"PE Verweij","year":"2024","unstructured":"Verweij PE, Song Y, Buil JB, et al. Antifungal resistance in pulmonary aspergillosis. Semin Respir Crit Care Med. 2024;45(32\u201340):20240109. https:\/\/doi.org\/10.1055\/s-0043-1776997.","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"339_CR98","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv163","volume":"2","author":"S Vallabhaneni","year":"2015","unstructured":"Vallabhaneni S, Cleveland AA, Farley MM, et al. Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008-2014. Open Forum Infect Dis. 2015;2(4):ofv163. https:\/\/doi.org\/10.1093\/ofid\/ofv163.","journal-title":"Open Forum Infect Dis"},{"key":"339_CR99","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/cit136","volume":"56","author":"BD Alexander","year":"2013","unstructured":"Alexander BD, Johnson MD, Pfeiffer CD, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56:1724\u201332. https:\/\/doi.org\/10.1093\/cid\/cit136.","journal-title":"Clin Infect Dis"},{"key":"339_CR100","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/cid\/ciu407","volume":"59","author":"ND Beyda","year":"2014","unstructured":"Beyda ND, John J, Kilic A, et al. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014;59:819\u201325. https:\/\/doi.org\/10.1093\/cid\/ciu407.","journal-title":"Clin Infect Dis"},{"key":"339_CR101","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","volume":"20","author":"MC Fisher","year":"2022","unstructured":"Fisher MC, Alastruey-Izquierdo A, Berman J, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022;20:557\u201371. https:\/\/doi.org\/10.1038\/s41579-022-00720-1.","journal-title":"Nat Rev Microbiol"},{"key":"339_CR102","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/cid\/cix257","volume":"65","author":"K Dunne","year":"2017","unstructured":"Dunne K, Hagen F, Pomeroy N, et al. Intercountry transfer of triazole-resistant Aspergillus fumigatus on plant bulbs. Clin Infect Dis. 2017;65:147\u20139. https:\/\/doi.org\/10.1093\/cid\/cix257.","journal-title":"Clin Infect Dis"},{"key":"339_CR103","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1056\/NEJMoa1714373","volume":"379","author":"DW Eyre","year":"2018","unstructured":"Eyre DW, Sheppard AE, Madder H, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med. 2018;379:1322\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1714373.","journal-title":"N Engl J Med"},{"key":"339_CR104","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11046-019-00366-3","volume":"184","author":"M Mac Aog\u00e1in","year":"2019","unstructured":"Mac Aog\u00e1in M, Chaturvedi V, Chotirmall SH. MycopathologiaGENOMES: the new \u201chome\u201d for the publication of fungal genomes. Mycopathologia. 2019;184:551\u20134. https:\/\/doi.org\/10.1007\/s11046-019-00366-3.","journal-title":"Mycopathologia"},{"key":"339_CR105","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMra012519","volume":"346","author":"AF Barker","year":"2002","unstructured":"Barker AF. Bronchiectasis. N Engl J Med. 2002;346:1383\u201393. https:\/\/doi.org\/10.1056\/NEJMra012519.","journal-title":"N Engl J Med"},{"issue":"1","key":"339_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-11-122","volume":"11","author":"A Agusti","year":"2010","unstructured":"Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122. https:\/\/doi.org\/10.1186\/1465-9921-11-122.","journal-title":"Respir Res"},{"issue":"5","key":"339_CR107","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1378\/chest.10-1758","volume":"140","author":"M Mart\u00ednez-Garc\u00eda","year":"2011","unstructured":"Mart\u00ednez-Garc\u00eda M, Soler-Catalu\u00f1a JJ, Donat Sanz Y, et al. Factors associated with bronchiectasis in patients with COPD. Chest. 2011;140(5):1130\u20137. https:\/\/doi.org\/10.1378\/chest.10-1758.","journal-title":"Chest"},{"issue":"4","key":"339_CR108","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1164\/rccm.200305-648OC","volume":"170","author":"IS Patel","year":"2004","unstructured":"Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):400\u20137. https:\/\/doi.org\/10.1164\/rccm.200305-648OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"339_CR109","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/thorax.55.8.635","volume":"55","author":"C O'Brien","year":"2000","unstructured":"O\u2019Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000;55:635\u201342. https:\/\/doi.org\/10.1136\/thorax.55.8.635.","journal-title":"Thorax"},{"issue":"3","key":"339_CR110","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1378\/chest.10-3007","volume":"140","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest. 2011;140(3):634\u201342. https:\/\/doi.org\/10.1378\/chest.10-3007.","journal-title":"Chest"},{"issue":"1247\u20131254","key":"339_CR111","doi-asserted-by":"publisher","first-page":"20170116","DOI":"10.1016\/j.chest.2016.12.024","volume":"151","author":"A De Soyza","year":"2017","unstructured":"De Soyza A, McDonnell MJ, Goeminne PC, et al. Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study. Chest. 2017;151(1247\u20131254):20170116. https:\/\/doi.org\/10.1016\/j.chest.2016.12.024.","journal-title":"Chest"},{"key":"339_CR112","doi-asserted-by":"publisher","first-page":"e002139","DOI":"10.1136\/bmjresp-2023-002139","volume":"12","author":"S Heraganahally","year":"2025","unstructured":"Heraganahally S, Gibbs C, Ravichandran SJ, et al. Retrospective cross-sectional study on bronchiectasis in adult Aboriginal Australians: disease characteristics and comparison with ethnically diverse global bronchiectasis registry cohorts. BMJ Open Respir Res. 2025;12:e002139. https:\/\/doi.org\/10.1136\/bmjresp-2023-002139.","journal-title":"BMJ Open Respir Res"},{"key":"339_CR113","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1183\/09031936.00170014","volume":"45","author":"JR Hurst","year":"2015","unstructured":"Hurst JR, Elborn JS, De Soyza A. COPD-bronchiectasis overlap syndrome. Eur Respir J. 2015;45:310\u20133. https:\/\/doi.org\/10.1183\/09031936.00170014.","journal-title":"Eur Respir J"},{"key":"339_CR114","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3109\/15412555.2014.922174","volume":"11","author":"T Gatheral","year":"2014","unstructured":"Gatheral T, Kumar N, Sansom B, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD J Chronic Obstr Pulm Dis. 2014;11:605\u201314. https:\/\/doi.org\/10.3109\/15412555.2014.922174.","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"issue":"1","key":"339_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/srep10961","volume":"5","author":"B Mao","year":"2015","unstructured":"Mao B, Lu HW, Li MH, et al. The existence of bronchiectasis predicts worse prognosis in patients with COPD. Sci Rep. 2015;5(1):10961. https:\/\/doi.org\/10.1038\/srep10961.","journal-title":"Sci Rep"},{"key":"339_CR116","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000004219","volume":"95","author":"J Jin","year":"2016","unstructured":"Jin J, Yu W, Li S, et al. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine (Baltimore). 2016;95:e4219. https:\/\/doi.org\/10.1097\/md.0000000000004219.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"339_CR117","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/crj.13294","volume":"15","author":"PY Tiew","year":"2021","unstructured":"Tiew PY, Jaggi TK, Chan LLY, et al. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap. Clin Respir J. 2021;15(2):123\u201333. https:\/\/doi.org\/10.1111\/crj.13294.","journal-title":"Clin Respir J"},{"key":"339_CR118","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02050-2020","author":"PY Tiew","year":"2021","unstructured":"Tiew PY, Dicker AJ, Keir HR, et al. A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.02050-2020.","journal-title":"Eur Respir J"},{"key":"339_CR119","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.chest.2021.07.2165","volume":"161","author":"PY Tiew","year":"2022","unstructured":"Tiew PY, Lim AYH, Keir HR, et al. High frequency of allergic bronchopulmonary aspergillosis in bronchiectasis-COPD overlap. Chest. 2022;161:40\u201353. https:\/\/doi.org\/10.1016\/j.chest.2021.07.2165.","journal-title":"Chest"},{"issue":"1","key":"339_CR120","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","volume":"15","author":"KF Budden","year":"2017","unstructured":"Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017;15(1):55\u201363. https:\/\/doi.org\/10.1038\/nrmicro.2016.142.","journal-title":"Nat Rev Microbiol"},{"key":"339_CR121","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02557-2017","author":"PC Goeminne","year":"2018","unstructured":"Goeminne PC, Cox B, Finch S, et al. The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis. Eur Respir J. 2018. https:\/\/doi.org\/10.1183\/13993003.02557-2017.","journal-title":"Eur Respir J"},{"key":"339_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105465","volume":"110","author":"S Hu","year":"2024","unstructured":"Hu S, Xue X, Xu J, et al. Association of short-term exposure to ambient air pollution and temperature with bronchiectasis mortality: a nationwide time-stratified case-crossover study. EBioMedicine. 2024;110:105465. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105465.","journal-title":"EBioMedicine"},{"key":"339_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2020.113654","volume":"231","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhou Y, Zhang Y, et al. Association of hospital admission for bronchiectasis with air pollution: a province-wide time-series study in southern China. Int J Hyg Environ Health. 2021;231:113654. https:\/\/doi.org\/10.1016\/j.ijheh.2020.113654.","journal-title":"Int J Hyg Environ Health"},{"key":"339_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1233516","volume":"10","author":"H Lee","year":"2023","unstructured":"Lee H, Kim SH, Lee SK, et al. Impact of air pollution on healthcare utilization in patients with bronchiectasis. Front Med Lausanne. 2023;10:1233516. https:\/\/doi.org\/10.3389\/fmed.2023.1233516.","journal-title":"Front Med Lausanne"},{"issue":"257\u2013261","key":"339_CR125","doi-asserted-by":"publisher","first-page":"20170726","DOI":"10.1016\/j.medcli.2017.06.022","volume":"150","author":"I Garcia-Oliv\u00e9","year":"2018","unstructured":"Garcia-Oliv\u00e9 I, Radua J, S\u00e1nchez-Berenguer D, et al. Association between environmental factors and hospitalisations for bronchiectasis in Badalona, Barcelona, Spain (2007\u20132015). Med Clin (Barc). 2018;150(257\u2013261):20170726. https:\/\/doi.org\/10.1016\/j.medcli.2017.06.022.","journal-title":"Med Clin (Barc)"},{"key":"339_CR126","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00418-2020","author":"PY Tiew","year":"2020","unstructured":"Tiew PY, Ko FWS, Pang SL, et al. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.00418-2020.","journal-title":"Eur Respir J"},{"key":"339_CR127","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00907-2024","author":"PY Tiew","year":"2024","unstructured":"Tiew PY, Leung JM, Mac Aog\u00e1in M, et al. Residential exposure to Aspergillus spp. is associated with exacerbations in COPD. Eur Respir J. 2024. https:\/\/doi.org\/10.1183\/13993003.00907-2024.","journal-title":"Eur Respir J"},{"key":"339_CR128","doi-asserted-by":"publisher","first-page":"12814","DOI":"10.1073\/pnas.0811003106","volume":"106","author":"J Fr\u00f6hlich-Nowoisky","year":"2009","unstructured":"Fr\u00f6hlich-Nowoisky J, Pickersgill DA, Despr\u00e9s VR, et al. High diversity of fungi in air particulate matter. Proc Natl Acad Sci U S A. 2009;106:12814\u20139. https:\/\/doi.org\/10.1073\/pnas.0811003106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"339_CR129","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1378\/chest.12-1363","volume":"143","author":"CG Baxter","year":"2013","unstructured":"Baxter CG, Moore CB, Jones AM, et al. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest. 2013;143:1351\u20137. https:\/\/doi.org\/10.1378\/chest.12-1363.","journal-title":"Chest"},{"key":"339_CR130","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1378\/chest.09-1103","volume":"137","author":"R Amin","year":"2010","unstructured":"Amin R, Dupuis A, Aaron SD, et al. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest. 2010;137:171\u20136. https:\/\/doi.org\/10.1378\/chest.09-1103.","journal-title":"Chest"},{"key":"339_CR131","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1164\/arrd.1979.120.4.863","volume":"120","author":"LA Nelson","year":"1979","unstructured":"Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis. 1979;120:863\u201373. https:\/\/doi.org\/10.1164\/arrd.1979.120.4.863.","journal-title":"Am Rev Respir Dis"},{"key":"339_CR132","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/thx.39.3.179","volume":"39","author":"MB Murphy","year":"1984","unstructured":"Murphy MB, Reen DJ, Fitzgerald MX. Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax. 1984;39:179. https:\/\/doi.org\/10.1136\/thx.39.3.179.","journal-title":"Thorax"},{"key":"339_CR133","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.2147\/copd.S141695","volume":"12","author":"S Everaerts","year":"2017","unstructured":"Everaerts S, Lagrou K, Dubbeldam A, et al. Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2629\u201338. https:\/\/doi.org\/10.2147\/copd.S141695.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"339_CR134","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1164\/rccm.201810-1949ED","volume":"199","author":"PJ McShane","year":"2019","unstructured":"McShane PJ. A new bronchiectasis endophenotype: immunoallertypes. Am J Respir Crit Care Med. 2019;199:811\u20132. https:\/\/doi.org\/10.1164\/rccm.201810-1949ED.","journal-title":"Am J Respir Crit Care Med"},{"key":"339_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104478","volume":"93","author":"PJ Beggs","year":"2023","unstructured":"Beggs PJ, Clot B, Sofiev M, et al. Climate change, airborne allergens, and three translational mitigation approaches. EBioMedicine. 2023;93:104478. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104478.","journal-title":"EBioMedicine"},{"issue":"2219\u20132228","key":"339_CR136","doi-asserted-by":"publisher","first-page":"20200805","DOI":"10.1111\/all.14476","volume":"75","author":"G D'Amato","year":"2020","unstructured":"D\u2019Amato G, Chong-Neto HJ, Monge Ortega OP, et al. The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens. Allergy. 2020;75(2219\u20132228):20200805. https:\/\/doi.org\/10.1111\/all.14476.","journal-title":"Allergy"},{"key":"339_CR137","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/jof9050544","volume":"9","author":"M Sztandera-Tymoczek","year":"2023","unstructured":"Sztandera-Tymoczek M, Szuster-Ciesielska A. Fungal aeroallergens\u2014the impact of climate change. J Fungi. 2023;9:544.","journal-title":"J Fungi"},{"key":"339_CR138","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl2746","volume":"386","author":"RC Thompson","year":"2024","unstructured":"Thompson RC, Courtene-Jones W, Boucher J, et al. Twenty years of microplastic pollution research\u2014what have we learned? Science. 2024;386:eadl2746. https:\/\/doi.org\/10.1126\/science.adl2746.","journal-title":"Science"},{"issue":"1","key":"339_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12989-018-0282-0","volume":"15","author":"TY Poh","year":"2018","unstructured":"Poh TY, Ali N, Mac Aog\u00e1in M, et al. Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives. Part Fibre Toxicol. 2018;15(1):46. https:\/\/doi.org\/10.1186\/s12989-018-0282-0.","journal-title":"Part Fibre Toxicol"},{"key":"339_CR140","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12989-024-00613-6","volume":"21","author":"Z Gou","year":"2024","unstructured":"Gou Z, Wu H, Li S, et al. Airborne micro- and nanoplastics: emerging causes of respiratory diseases. Part Fibre Toxicol. 2024;21:50. https:\/\/doi.org\/10.1186\/s12989-024-00613-6.","journal-title":"Part Fibre Toxicol"},{"key":"339_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24355","author":"SC Saha","year":"2024","unstructured":"Saha SC, Saha G. Effect of microplastics deposition on human lung airways: a review with computational benefits and challenges. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24355.","journal-title":"Heliyon"},{"key":"339_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2024.114776","volume":"190","author":"Q Wu","year":"2024","unstructured":"Wu Q, Li R, You Y, et al. Lung microbiota participated in fibrous microplastics (MPs) aggravating OVA-induced asthma disease in mice. Food Chem Toxicol. 2024;190:114776. https:\/\/doi.org\/10.1016\/j.fct.2024.114776.","journal-title":"Food Chem Toxicol"},{"key":"339_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15104","volume":"9","author":"A Parsaeimehr","year":"2023","unstructured":"Parsaeimehr A, Miller CM, Ozbay G. Microplastics and their interactions with microbiota. Heliyon. 2023;9:e15104. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15104.","journal-title":"Heliyon"},{"issue":"1492759","key":"339_CR144","doi-asserted-by":"publisher","first-page":"20241125","DOI":"10.3389\/fcimb.2024.1492759","volume":"14","author":"SS Bora","year":"2024","unstructured":"Bora SS, Gogoi R, Sharma MR, et al. Microplastics and human health: unveiling the gut microbiome disruption and chronic disease risks. Front Cell Infect Microbiol. 2024;14(1492759):20241125. https:\/\/doi.org\/10.3389\/fcimb.2024.1492759.","journal-title":"Front Cell Infect Microbiol"},{"key":"339_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.177045","volume":"955","author":"Z Ullah","year":"2024","unstructured":"Ullah Z, Peng L, Lodhi AF, et al. The threat of microplastics and microbial degradation potential; a current perspective. Sci Total Environ. 2024;955:177045. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.177045.","journal-title":"Sci Total Environ"},{"key":"339_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2021.113045","volume":"229","author":"P Fan","year":"2022","unstructured":"Fan P, Tan W, Yu H. Effects of different concentrations and types of microplastics on bacteria and fungi in alkaline soil. Ecotoxicol Environ Saf. 2022;229:113045. https:\/\/doi.org\/10.1016\/j.ecoenv.2021.113045.","journal-title":"Ecotoxicol Environ Saf"},{"key":"339_CR147","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41579-024-01077-3","volume":"22","author":"JA Gilbert","year":"2024","unstructured":"Gilbert JA, Hartmann EM. The indoors microbiome and human health. Nat Rev Microbiol. 2024;22:742\u201355. https:\/\/doi.org\/10.1038\/s41579-024-01077-3.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"339_CR148","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1039\/d4em00392f","volume":"26","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Liu S, Wang W, et al. Associations of indoor airborne microbiome with lung function: evidence from a randomized, double-blind, crossover study of microbial intervention. Environ Sci Process Impacts. 2024;26(11):2020\u201335. https:\/\/doi.org\/10.1039\/d4em00392f.","journal-title":"Environ Sci Process Impacts"},{"key":"339_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.buildenv.2024.111264","volume":"253","author":"I Luhung","year":"2024","unstructured":"Luhung I, Lim SBY, Uchida A, et al. Understanding diel bioaerosol patterns in mold-affected buildings through metagenomic surveillance. Build Environ. 2024;253:111264. https:\/\/doi.org\/10.1016\/j.buildenv.2024.111264.","journal-title":"Build Environ"},{"issue":"2","key":"339_CR150","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0044-2023","volume":"19","author":"A Guillien","year":"2023","unstructured":"Guillien A, Ghosh M, Gille T, et al. The exposome concept: how has it changed our understanding of environmental causes of chronic respiratory diseases? Breathe. 2023;19(2):230044. https:\/\/doi.org\/10.1183\/20734735.0044-2023.","journal-title":"Breathe"},{"key":"339_CR151","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/all.13812","volume":"74","author":"H Sbihi","year":"2019","unstructured":"Sbihi H, Boutin RC, Cutler C, et al. Thinking bigger: how early-life environmental exposures shape the gut microbiome and influence the development of asthma and allergic disease. Allergy. 2019;74:2103\u201315. https:\/\/doi.org\/10.1111\/all.13812.","journal-title":"Allergy"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-025-00339-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:31:18Z","timestamp":1773667878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-025-00339-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":151,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1007\/s41030-025-00339-6","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sanjay H. Chotirmall has served on advisory boards for CSL Behring, Pneumagen Ltd., Zaccha Pte Ltd, Boehringer Ingelheim, GSK and Sanofi, on DSMBs for Inovio Pharmaceuticals and Imam Abdulrahman Bin Faisal University and has received personal fees from AstraZeneca and Chiesi Farmaceutici, all unrelated to this work. Kai Xian Thng and Miche\u00e1l Mac Aog\u00e1in have no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}